Small molecules for the modulation of MCL-1 and methods of modulatiing cell death, cell division, cell differentiation and methods of treating disorders

Details for Australian Patent Application No. 2011210567 (hide)

Owner Dana-Farber Cancer Institute, Inc.

Inventors Walensky, Loren D.; Stewart, Michelle L.; Cohen, Nicole

Agent Pizzeys

Pub. Number AU-A-2011210567

PCT Pub. Number WO2011/094708

Priority 61/299,803 29.01.10 US

Filing date 31 January 2011

Wipo publication date 4 August 2011

International Classifications

C07C 251/20 Compounds containing nitrogen atoms doubly- bound to a carbon skeleton

A61K 31/41 - having five-membered rings with two or more ring hetero atoms, at least one of which is nitrogen, e.g. tetrazole

A61P 35/00 Antineoplastic agents

C07D 215/16 Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems

C07D 249/08 Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms

Event Publications

9 August 2012 PCT application entered the National Phase

  PCT publication WO2011/094708 Priority application(s): WO2011/094708

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2011210583-Car top carrier lid support

2011210557-Method and device for female therapeutic massage